EMEA (Europe, Middle East and Africa) Antifungal Drugs Market Report 2017

July 2017 | 111 pages | ID: E4471681FF3EN
QYResearch

Abstracts

In this report, the EMEA Antifungal Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Antifungal Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Antifungal Drugs market competition by top manufacturers/players, with Antifungal Drugs sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer Healthcare
• Sanofi-Aventis
• Novartis
• Pfizer Inc.
• Abbott Laboratories
• Merck & Co. Inc.
• GlaxoSmithKline
• ID Sigma-Aldrich Corporation
• Astellas Pharma Inc
• Glenmark Pharmaceuticals Ltd
• Enzon Pharmaceuticals
• SRS Pharmaceuticals Pvt. Ltd.
• Naman Pharma Drugs

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

• Azoles
• Echinocandins
• Polyenes
• Allyamines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Antifungal Drugs for each application, including

• Dermatophytosis
• Aspergillosis
• Candidiasis

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Antifungal Drugs Market Report 2017

1 ANTIFUNGAL DRUGS OVERVIEW

1.1 Product Overview and Scope of Antifungal Drugs
1.2 Classification of Antifungal Drugs
  1.2.1 EMEA Antifungal Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Antifungal Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Azoles
  1.2.4 Echinocandins
  1.2.5 Polyenes
  1.2.6 Allyamines
1.3 EMEA Antifungal Drugs Market by Application/End Users
  1.3.1 EMEA Antifungal Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Dermatophytosis
  1.3.3 Aspergillosis
  1.3.4 Candidiasis
1.4 EMEA Antifungal Drugs Market by Region
  1.4.1 EMEA Antifungal Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Antifungal Drugs (2012-2022)
  1.5.1 EMEA Antifungal Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Antifungal Drugs Revenue and Growth Rate (2012-2022)

2 EMEA ANTIFUNGAL DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Antifungal Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Antifungal Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Antifungal Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Antifungal Drugs Sale Price by Players (2012-2017)
2.2 EMEA Antifungal Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Antifungal Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Antifungal Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Antifungal Drugs Sale Price by Type (2012-2017)
2.3 EMEA Antifungal Drugs (Volume) by Application
2.4 EMEA Antifungal Drugs (Volume and Value) by Region
  2.4.1 EMEA Antifungal Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Antifungal Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Antifungal Drugs Sales Price by Region (2012-2017)

3 EUROPE ANTIFUNGAL DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Antifungal Drugs Sales and Value (2012-2017)
  3.1.1 Europe Antifungal Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Antifungal Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Antifungal Drugs Sales and Market Share by Type
3.3 Europe Antifungal Drugs Sales and Market Share by Application
3.4 Europe Antifungal Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Antifungal Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Antifungal Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Antifungal Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Antifungal Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Antifungal Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Antifungal Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Antifungal Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Antifungal Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTIFUNGAL DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Antifungal Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Antifungal Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Antifungal Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Antifungal Drugs Sales and Market Share by Type
4.3 Middle East Antifungal Drugs Sales and Market Share by Application
4.4 Middle East Antifungal Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Antifungal Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Antifungal Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Antifungal Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Antifungal Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Antifungal Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Antifungal Drugs Sales and Growth Rate (2012-2017)

5 AFRICA ANTIFUNGAL DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Antifungal Drugs Sales and Value (2012-2017)
  5.1.1 Africa Antifungal Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Antifungal Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Antifungal Drugs Sales and Market Share by Type
5.3 Africa Antifungal Drugs Sales and Market Share by Application
5.4 Africa Antifungal Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Antifungal Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Antifungal Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Antifungal Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Antifungal Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Antifungal Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Antifungal Drugs Sales and Growth Rate (2012-2017)

6 EMEA ANTIFUNGAL DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bayer Healthcare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antifungal Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Healthcare Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi-Aventis
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Antifungal Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi-Aventis Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Antifungal Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Antifungal Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Inc. Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott Laboratories
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Antifungal Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Laboratories Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck & Co. Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Antifungal Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck & Co. Inc. Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Antifungal Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GlaxoSmithKline Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 ID Sigma-Aldrich Corporation
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Antifungal Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 ID Sigma-Aldrich Corporation Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Astellas Pharma Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Antifungal Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Astellas Pharma Inc Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Glenmark Pharmaceuticals Ltd
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Antifungal Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Glenmark Pharmaceuticals Ltd Antifungal Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Enzon Pharmaceuticals
6.12 SRS Pharmaceuticals Pvt. Ltd.
6.13 Naman Pharma Drugs

7 ANTIFUNGAL DRUGS MANUFACTURING COST ANALYSIS

7.1 Antifungal Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antifungal Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antifungal Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antifungal Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTIFUNGAL DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Antifungal Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Antifungal Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Antifungal Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Antifungal Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Antifungal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Antifungal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Antifungal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Antifungal Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Antifungal Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Antifungal Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antifungal Drugs
Figure EMEA Antifungal Drugs Sales Volume (MT) by Type (2012-2022)
Figure EMEA Antifungal Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Azoles Product Picture
Figure Echinocandins Product Picture
Figure Polyenes Product Picture
Figure Allyamines Product Picture
Figure EMEA Antifungal Drugs Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Antifungal Drugs by Application in 2016
Figure Dermatophytosis Examples
Table Key Downstream Customer in Dermatophytosis
Figure Aspergillosis Examples
Table Key Downstream Customer in Aspergillosis
Figure Candidiasis Examples
Table Key Downstream Customer in Candidiasis
Figure EMEA Antifungal Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Antifungal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antifungal Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Antifungal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Antifungal Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Antifungal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Antifungal Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Antifungal Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Antifungal Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Antifungal Drugs Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Antifungal Drugs Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Antifungal Drugs Sales Share by Players (2012-2017)
Figure 2016 Antifungal Drugs Sales Share by Players
Figure 2017 Antifungal Drugs Sales Share by Players
Figure EMEA Antifungal Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Antifungal Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Antifungal Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Antifungal Drugs Revenue Share by Players
Table 2017 EMEA Antifungal Drugs Revenue Share by Players
Table EMEA Antifungal Drugs Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Antifungal Drugs Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Antifungal Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Antifungal Drugs by Type (2012-2017)
Figure EMEA Antifungal Drugs Sales Market Share by Type (2012-2017)
Table EMEA Antifungal Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Antifungal Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antifungal Drugs by Type in 2016
Table EMEA Antifungal Drugs Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Antifungal Drugs Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Antifungal Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Antifungal Drugs by Application (2012-2017)
Figure EMEA Antifungal Drugs Sales Market Share by Application in 2016
Table EMEA Antifungal Drugs Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Antifungal Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Antifungal Drugs by Region (2012-2017)
Figure EMEA Antifungal Drugs Sales Market Share in 2016
Table EMEA Antifungal Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Antifungal Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Antifungal Drugs by Region (2012-2017)
Figure EMEA Antifungal Drugs Revenue Market Share Regions in 2016
Table EMEA Antifungal Drugs Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Europe Antifungal Drugs Revenue and Growth Rate (2012-2017)
Table Europe Antifungal Drugs Sales (MT) by Type (2012-2017)
Table Europe Antifungal Drugs Market Share by Type (2012-2017)
Figure Europe Antifungal Drugs Market Share by Type in 2016
Table Europe Antifungal Drugs Sales (MT) by Application (2012-2017)
Table Europe Antifungal Drugs Market Share by Application (2012-2017)
Figure Europe Antifungal Drugs Market Share by Application in 2016
Table Europe Antifungal Drugs Sales (MT) by Countries (2012-2017)
Table Europe Antifungal Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Antifungal Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Antifungal Drugs Sales Market Share by Countries in 2016
Table Europe Antifungal Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Antifungal Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Antifungal Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Antifungal Drugs Revenue Market Share by Countries in 2016
Figure Germany Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure France Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UK Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Russia Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Italy Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Antifungal Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Antifungal Drugs Sales (MT) by Type (2012-2017)
Table Middle East Antifungal Drugs Market Share by Type (2012-2017)
Figure Middle East Antifungal Drugs Market Share by Type (2012-2017)
Table Middle East Antifungal Drugs Sales (MT) by Applications (2012-2017)
Table Middle East Antifungal Drugs Market Share by Applications (2012-2017)
Figure Middle East Antifungal Drugs Sales Market Share by Application in 2016
Table Middle East Antifungal Drugs Sales Volume (MT) by Countries (2012-2017)
Table Middle East Antifungal Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Antifungal Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Antifungal Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Antifungal Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Antifungal Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Antifungal Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Israel Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure UAE Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Iran Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Africa Antifungal Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Antifungal Drugs Sales (MT) by Type (2012-2017)
Table Africa Antifungal Drugs Sales Market Share by Type (2012-2017)
Figure Africa Antifungal Drugs Sales Market Share by Type (2012-2017)
Figure Africa Antifungal Drugs Sales Market Share by Type in 2016
Table Africa Antifungal Drugs Sales (MT) by Application (2012-2017)
Table Africa Antifungal Drugs Sales Market Share by Application (2012-2017)
Figure Africa Antifungal Drugs Sales Market Share by Application (2012-2017)
Table Africa Antifungal Drugs Sales Volume (MT) by Countries (2012-2017)
Table Africa Antifungal Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Antifungal Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Antifungal Drugs Sales Market Share by Countries in 2016
Table Africa Antifungal Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Antifungal Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Antifungal Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Antifungal Drugs Revenue Market Share by Countries in 2016
Figure South Africa Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Table Bayer Healthcare Antifungal Drugs Basic Information List
Table Bayer Healthcare Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer Healthcare Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Bayer Healthcare Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Healthcare Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis Antifungal Drugs Basic Information List
Table Sanofi-Aventis Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis Antifungal Drugs Basic Information List
Table Novartis Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Novartis Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc. Antifungal Drugs Basic Information List
Table Pfizer Inc. Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc. Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer Inc. Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc. Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Antifungal Drugs Basic Information List
Table Abbott Laboratories Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbott Laboratories Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Abbott Laboratories Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck & Co. Inc. Antifungal Drugs Basic Information List
Table Merck & Co. Inc. Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co. Inc. Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Merck & Co. Inc. Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck & Co. Inc. Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Antifungal Drugs Basic Information List
Table GlaxoSmithKline Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table ID Sigma-Aldrich Corporation Antifungal Drugs Basic Information List
Table ID Sigma-Aldrich Corporation Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ID Sigma-Aldrich Corporation Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure ID Sigma-Aldrich Corporation Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure ID Sigma-Aldrich Corporation Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table Astellas Pharma Inc Antifungal Drugs Basic Information List
Table Astellas Pharma Inc Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Astellas Pharma Inc Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Inc Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table Glenmark Pharmaceuticals Ltd Antifungal Drugs Basic Information List
Table Glenmark Pharmaceuticals Ltd Antifungal Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Glenmark Pharmaceuticals Ltd Antifungal Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Glenmark Pharmaceuticals Ltd Antifungal Drugs Sales Market Share in EMEA (2012-2017)
Figure Glenmark Pharmaceuticals Ltd Antifungal Drugs Revenue Market Share in EMEA (2012-2017)
Table Enzon Pharmaceuticals Antifungal Drugs Basic Information List
Table SRS Pharmaceuticals Pvt. Ltd. Antifungal Drugs Basic Information List
Table Naman Pharma Drugs Antifungal Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antifungal Drugs
Figure Manufacturing Process Analysis of Antifungal Drugs
Figure Antifungal Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antifungal Drugs Major Manufacturers in 2016
Table Major Buyers of Antifungal Drugs
Table Distributors/Traders List
Figure EMEA Antifungal Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Antifungal Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Antifungal Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Antifungal Drugs Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Antifungal Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Antifungal Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Antifungal Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Antifungal Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Antifungal Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Antifungal Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Antifungal Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Antifungal Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Antifungal Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Antifungal Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Antifungal Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Antifungal Drugs Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Antifungal Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Antifungal Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Antifungal Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Antifungal Drugs Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Antifungal Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Antifungal Drugs Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Antifungal Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources